Moderna will sell its vaccine to states $ 25–37 per dose. This is noticeably more expensive than a competing vaccine and an order of magnitude more expensive than the poor countries are ready to pay.

About the cost of the vaccine, depending on the volume of the order, the chief executive director of Moderna Stefan Bantzel told the German weekly Welt Am Sonntag. According to him, this is a fair price, which is “obviously less than the costs of the healthcare system for the treatment of a patient with COVID-19 in severe form”, and the company does not extract super-profits. By the end of the year, she must have time to produce 20 million doses.
The top manager is sure that in a few days an agreement on deliveries to the European Union will be signed. For these supplies, the price of $ 25 per dose was independently called. The competitor - the PFIZER vaccine -will cost much cheaper for the EU - $ 15.5 per dose (vaccination with both drugs requires two doses spaced in time).
The other day, the famous Indian professor-infectious disease specialist Ganandip Kang said that the Moderna vaccine will be inaccessible to mass vaccination in India at a price, and Pfizer vaccine-due to the need for low-temperature storage. The specialist noted that India never paid more than $ 3 for a mass vaccine and that she hopes most for the “Oxford” vaccine from Astrazeneca.
The ASTRAZENECA vaccine has not yet completed clinical trials, but showed encouraging results for the elderly. It is important that the pre -declared price of this vaccine will be in the region of $ 4-5 per dose.
The day before, President Putinsaid that Russia is ready to provide “needy countries” with its vaccines from coronavirus. The FAS was ready to limit the maximum cost of the Russian vaccine 1000 rubles per dose, the manufacturers did not promise an export price below $ 5 per dose in the first episodes.